| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/08/2023 | Kymera Therapeutics, Inc. | | Exercise | Stock Option (Right to Buy) | 12k | $2.08 | $25k | | 08/08/2023 |
| 12/08/2022 | Kymera Therapeutics, Inc. | | Exercise | Stock Option (Right to Buy) | 10k | $2.08 | $20.8k | | 12/08/2022 |
| 10/17/2022 | Kymera Therapeutics, Inc. | | Exercise | Stock Option (Right to Buy) | 32.1k | $2.08 | $66.7k | | 10/17/2022 |
| 10/17/2022 | Kymera Therapeutics, Inc. | | Exercise | Stock Option (Right to Buy) | 27.7k | $2.08 | $57.6k | | 10/17/2022 |
| 05/03/2022 | Kymera Therapeutics, Inc. | | Exercise | Stock Option (Right to Buy) | 20k | $2.08 | $41.6k | | 05/03/2022 |
| 03/01/2022 | Kymera Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 275.1k | $38.53 | $10.6M | | 03/01/2022 |
| 01/14/2022 | Kymera Therapeutics, Inc. | | Exercise | Stock Option (Right to Buy) | 10k | $2.08 | $20.8k | | 01/14/2022 |
| 01/12/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 2.7k | $51.31 | $139.9k | | 01/10/2022 |
| 01/12/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 4k | $52.02 | $209.2k | | 01/10/2022 |
| 01/12/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 1.6k | $53.27 | $86.5k | | 01/10/2022 |
| 01/12/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 241 | $53.97 | $13k | | 01/10/2022 |
| 01/12/2022 | Kymera Therapeutics, Inc. | | Exercise | Stock Option (Right to Buy) | 8.6k | $2.08 | $17.9k | | 01/10/2022 |
| 01/11/2022 | Kymera Therapeutics, Inc. | | Exercise | Stock Option (Right to Buy) | 16.9k | $2.08 | $35.2k | | 01/10/2022 |
| 01/11/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 9.9k | $53.68 | $533.1k | | 01/10/2022 |
| 01/11/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 6.6k | $54.42 | $361.6k | | 01/10/2022 |
| 01/11/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 347 | $55.05 | $19.1k | | 01/10/2022 |
| 01/10/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 7.5k | $52.46 | $392.6k | | 01/10/2022 |
| 01/10/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 10.7k | $53.35 | $569.4k | | 01/10/2022 |
| 01/10/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 4.2k | $54.40 | $228.5k | | 01/10/2022 |
| 01/10/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 106 | $54.99 | $5.8k | | 01/10/2022 |
| 01/10/2022 | Kymera Therapeutics, Inc. | | Exercise | Stock Option (Right to Buy) | 22.5k | $2.08 | $46.7k | | 01/10/2022 |
| 12/16/2021 | Kymera Therapeutics, Inc. | | Exercise | Stock Option (Right to Buy) | 8k | $2.08 | $16.6k | | 12/16/2021 |
| 10/11/2021 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 5.7k | $53.58 | $306k | | 10/08/2021 |
| 10/11/2021 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 744 | $54.50 | $40.5k | | 10/08/2021 |
| 10/11/2021 | Kymera Therapeutics, Inc. | | Exercise | Stock Option (Right to Buy) | 6.5k | $2.08 | $13.4k | | 10/08/2021 |
| 10/08/2021 | Kymera Therapeutics, Inc. | | Exercise | Stock Option (Right to Buy) | 41.5k | $2.08 | $86.4k | | 10/08/2021 |
| 10/08/2021 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 21.2k | $55.56 | $1.2M | | 10/08/2021 |
| 10/08/2021 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 9.4k | $56.82 | $532.4k | | 10/08/2021 |
| 10/08/2021 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 2.1k | $57.29 | $119k | | 10/08/2021 |
| 10/08/2021 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 7.9k | $59.28 | $469.5k | | 10/08/2021 |
| 10/08/2021 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 670 | $60.32 | $40.4k | | 10/08/2021 |
| 10/08/2021 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 271 | $61.87 | $16.8k | | 10/08/2021 |
| 08/02/2021 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 21.6k | $60.21 | $1.3M | | 07/29/2021 |
| 08/02/2021 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 1.5k | $61.28 | $93.4k | | 07/29/2021 |
| 08/02/2021 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 300 | $62.21 | $18.7k | | 07/29/2021 |
|